Testarea anuală a testosteronului în armata SUA, criticată de experți. Terapia poate provoca infertilitate și alte riscuri

The Pentagon's new annual testosterone testing policy for U.S. military personnel raises concerns among medical experts about potential unnecessary hormone therapy prescriptions. While aimed at enhancing combat readiness, specialists warn of significant side effects, including infertility and increased stroke risk. Starting July 15, all active-duty and reserve military members over 30 will undergo testing, which experts believe exceeds current medical guidelines. Isolated low testosterone results may not warrant treatment, as hormone levels can fluctuate due to various factors. Critics highlight the risk of over-prescription, with some military personnel receiving testosterone therapy without meeting medical criteria. Experts stress that therapy should only be recommended for diagnosed hormonal deficiencies, and caution against potential fertility issues and other adverse effects.